Changes in Beneficial Ownership · 4
Geron Corporation
GERNNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
form4-11162026_041103.xml
Filing details
- Report period
- 2026-11-16
- Issuer
- GERON CORP
- Issuer CIK
- 0000886744
- Trading symbol
- GERN
Reporting owner 1
- Name
- Williams Timothy
- Reporting owner CIK
- 0001748392
- Relationship
- Officer
- Officer title
- EVP and Chief Legal Officer
- Address
- C/O GERON CORPORATION, 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-11-16 | P · Form 4 | 12,000 | A | 0.94 | 12,000 | D |
Table key
- P · Form 4
- Purchase on the market or privately
- A
- Acquired
- D
- Direct
Signature 1
- Signed
- /s/ Timothy Williams
- Date
- 2026-11-16
Company context
meaningful moments for people living with blood cancer. Because patients cannot wait, we approach our work with urgency, bringing together deep expertise in telomerase biology with patient perspectives and insights from clinical research and real-world care. Our medicine, RYTELO® (imetelstat), is approved in the United States and European Union for certain patients with lower-risk myelodysplastic syndromes (LR-MDS). Geron is a commercial-stage company with offices in Parsippany, New Jersey and Foster City, California. To learn more, visit www.geron.com or follow us on LinkedIn.